Title |
Antitumor effect of therapeutic HPV DNA vaccines with chitosan-based nanodelivery systems
|
---|---|
Published in |
Journal of Biomedical Science, July 2014
|
DOI | 10.1186/s12929-014-0069-z |
Pubmed ID | |
Authors |
Alireza Tahamtan, Amir Ghaemi, Ali Gorji, Hamid R Kalhor, Azadeh Sajadian, Alijan Tabarraei, Abdolvahab Moradi, Fatemeh Atyabi, Mishar Kelishadi |
Abstract |
BackgroundCervical cancer is the second-most-common cause of malignancies in women worldwide, and the oncogenic activity of the human papilloma virus types (HPV) E7 protein has a crucial role in anogenital tumors. In this study, we have designed a therapeutic vaccine based on chitosan nanodelivery systems to deliver HPV-16 E7 DNA vaccine, considered as a tumor specific antigen for immunotherapy of HPV-associated cervical cancer. We have developed a Nano-chitosan (NCS) as a carrier system for intramuscular administration using a recombinant DNA vaccine expressing HPV-16 E7 (NCS-DNA E7 vaccine). NCS were characterized in vitro for their gene transfection ability.ResultsThe transfection of CS-pEGFP NPs was efficient in CHO cells and the expression of green fluorescent proteins was well observed. In addition, NCS-DNA E7 vaccine induced the strongest E7-specific CD8+ T cell and interferon ¿ responses in C57BL/6 mice. Mice vaccinated with NCS-DNA E7 vaccine were able to generate potent protective and therapeutic antitumor effects against challenge with E7-expressing tumor cell line, TC-1.ConclusionsThe strong therapeutic effect induced by the Chitosan-based nanodelivery suggest that nanoparticles may be an efficient carrier to improve the immunogenicity of DNA vaccination upon intramuscular administration and the platform could be further exploited as a potential cancer vaccine candidate in humans. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Lebanon | 1 | <1% |
United States | 1 | <1% |
Unknown | 105 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 29 | 27% |
Student > Ph. D. Student | 21 | 20% |
Student > Master | 12 | 11% |
Researcher | 6 | 6% |
Lecturer | 4 | 4% |
Other | 18 | 17% |
Unknown | 17 | 16% |
Readers by discipline | Count | As % |
---|---|---|
Pharmacology, Toxicology and Pharmaceutical Science | 31 | 29% |
Medicine and Dentistry | 19 | 18% |
Biochemistry, Genetics and Molecular Biology | 14 | 13% |
Immunology and Microbiology | 8 | 7% |
Agricultural and Biological Sciences | 5 | 5% |
Other | 9 | 8% |
Unknown | 21 | 20% |